Cochlear loses final appeal hope in infringement case

MELBOURNE: Hearing implant maker Cochlear has lost its final chance to appeal the ... read more

Mesoblast shares savaged on poor COVID trial results

MELBOURNE: Stem cell biotech Mesoblast has had its share price smashed after the ... read more

RAM bulks up for float with triple hospital deal

SYDNEY: Real Asset Management (RAM) has reached its target of $500 million of ... read more

Suitors scan Capitol Health amid demand for healthcare assets

MELBOURNE: Diagnostic imaging provider Capitol Health is being touted as a likely takeover ... read more